| Bioengineering human myocardium on native extracellular matrix JP Guyette, JM Charest, RW Mills, BJ Jank, PT Moser, SE Gilpin, ... Circulation research 118 (1), 56-72, 2016 | 387 | 2016 |
| Engineered composite tissue as a bioartificial limb graft BJ Jank, L Xiong, PT Moser, JP Guyette, X Ren, CL Cetrulo, DA Leonard, ... Biomaterials 61, 246-256, 2015 | 134 | 2015 |
| Ex vivo non-invasive assessment of cell viability and proliferation in bio-engineered whole organ constructs X Ren, LF Tapias, BJ Jank, DJ Mathisen, M Lanuti, HC Ott Biomaterials 52, 103-112, 2015 | 64 | 2015 |
| The molecular march of primary and recurrent nasopharyngeal carcinoma NJ Campion, M Ally, BJ Jank, J Ahmed, G Alusi Oncogene 40 (10), 1757-1774, 2021 | 44 | 2021 |
| Creation of a bioengineered skin flap scaffold with a perfusable vascular pedicle BJ Jank, J Goverman, JP Guyette, JM Charest, M Randolph, GR Gaudette, ... Tissue engineering Part A 23 (13-14), 696-707, 2017 | 41 | 2017 |
| Prognostic value of advanced lung cancer inflammation index in head and neck squamous cell carcinoma BJ Jank, L Kadletz, J Schnöll, E Selzer, C Perisanidis, G Heiduschka European Archives of Oto-Rhino-Laryngology 276, 1487-1492, 2019 | 27 | 2019 |
| Creation of laryngeal grafts from primary human cells and decellularized laryngeal scaffolds PT Moser, M Gerli, GR Diercks, D Evangelista-Leite, JM Charest, ... Tissue Engineering Part A 26 (9-10), 543-555, 2020 | 22 | 2020 |
| The geriatric nutritional risk index (GNRI) as a prognostic biomarker for immune checkpoint inhibitor response in recurrent and/or metastatic head and neck cancer M Haas, A Lein, T Fuereder, FF Brkic, J Schnoell, DT Liu, ... Nutrients 15 (4), 880, 2023 | 21 | 2023 |
| Impact of pretherapeutic neutrophil-to-lymphocyte ratio, serum albumin, body-mass index, and advanced lung cancer inflammation index on clinical outcome in sinonasal squamous … FF Brkic, L Kadletz, B Jank, C Mayer, G Heiduschka, M Brunner Journal of Cranio-Maxillofacial Surgery 48 (1), 33-37, 2020 | 19 | 2020 |
| Radiogenomic markers enable risk stratification and inference of mutational pathway states in head and neck cancer CP Spielvogel, S Stoiber, L Papp, D Krajnc, M Grahovac, E Gurnhofer, ... European Journal of Nuclear Medicine and Molecular Imaging 50 (2), 546-558, 2023 | 18 | 2023 |
| An analysis of distant metastasis cases from HPV-associated oropharyngeal squamous cell carcinoma FF Brkic, L Kadletz-Wanke, L Kenner, T Füreder, B Jank, M Brunner, ... Journal of Cranio-Maxillofacial Surgery 49 (4), 312-316, 2021 | 17 | 2021 |
| Pretreatment assessment of hematologic and inflammatory markers in adenoid cystic carcinoma: Neutrophil/lymphocyte ratio is associated with multiple recurrences FF Brkic, L Kadletz, B Jank, J Cede, R Seemann, S Schneider, ... Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 127 (5), 408-416, 2019 | 13 | 2019 |
| Radiosensitizing effect of galunisertib, a TGF-ß receptor I inhibitor, on head and neck squamous cell carcinoma in vitro BJ Jank, T Lenz, M Haas, L Kadletz-Wanke, NJ Campion, J Schnoell, ... Investigational New Drugs 40 (3), 478-486, 2022 | 12 | 2022 |
| Transcription factors CP2 and YY1 as prognostic markers in head and neck squamous cell carcinoma: analysis of The Cancer Genome Atlas and a second independent cohort J Schnoell, BJ Jank, L Kadletz-Wanke, S Stoiber, CP Spielvogel, ... Journal of cancer research and clinical oncology 147, 755-765, 2021 | 10 | 2021 |
| Expression of inhibitors of apoptosis proteins in salivary gland adenoid cystic carcinoma: XIAP is an independent marker of impaired cause‐specific survival J Schnoell, L Kadletz, BJ Jank, F Oberndorfer, FF Brkic, E Gurnhofer, ... Clinical Otolaryngology 45 (3), 364-369, 2020 | 10 | 2020 |
| Evaluation of the cancer stem cell marker DCLK1 in patients with lymph node metastases of head and neck cancer L Kadletz, L Kenner, R Wiebringhaus, B Jank, C Mayer, E Gurnhofer, ... Pathology-Research and Practice 215 (12), 152698, 2019 | 10 | 2019 |
| The association between COVID-19 cases and deaths and web-based public inquiries J Schnoell, G Besser, BJ Jank, TJ Bartosik, T Parzefall, D Riss, ... Infectious Diseases 53 (3), 176-183, 2021 | 9 | 2021 |
| Early on-treatment C-reactive protein and its kinetics predict survival and response in recurrent and/or metastatic head and neck cancer patients receiving first-line pembrolizumab M Haas, A Lein, T Fuereder, J Schnoell, FF Brkic, DT Liu, ... Investigational New Drugs 41 (5), 727-736, 2023 | 8 | 2023 |
| The radiosensitizing effect of β-Thujaplicin, a tropolone derivative inducing S-phase cell cycle arrest, in head and neck squamous cell carcinoma-derived cell lines M Haas, T Lenz, L Kadletz-Wanke, G Heiduschka, BJ Jank Investigational New Drugs 40 (4), 700-708, 2022 | 7 | 2022 |
| Zerumbone acts as a radiosensitizer in head and neck squamous cell carcinoma J Schnoell, I Stanisz, BJ Jank, V Stanek, R Schmid, M Brunner, ... Investigational New Drugs, 1-8, 2022 | 7 | 2022 |
